Erin E. Tapper
Impact in
-
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
-
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 10
- CAR-T cell therapy research 9
-
- CRISPR and Genetic Engineering 2
- Extracellular vesicles in disease 2
- Co-authors
- Mehrdad Hefazi (10 shared papers)Michelle J. Cox (10 shared papers)Michael W. Ruff (10 shared papers)Saad S. Kenderian (10 shared papers)Reona Sakemura (11 shared papers)Claudia Manriquez Roman (10 shared papers)Kendall J. Schick (10 shared papers)Paulina Horvei (7 shared papers)
- Journals
- Blood (6 papers)Biology of Blood and Marrow Transplantation (4 papers)JCO Precision Oncology (1 paper)Cancer Research (1 paper)Cytotherapy (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Erin E. Tapper
12 papers receiving 81 citations
Peers
Comparison fields: 5 of 18
- Oncology 62
- Pathology and Forensic Medicine 12
- Genetics 6
- Immunology 11
- Molecular Biology 35
Countries citing papers authored by Erin E. Tapper
This map shows the geographic impact of Erin E. Tapper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin E. Tapper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin E. Tapper more than expected).
Fields of papers citing papers by Erin E. Tapper
This network shows the impact of papers produced by Erin E. Tapper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin E. Tapper. The network helps show where Erin E. Tapper may publish in the future.
Co-authors
The 25 scholars most cited alongside Erin E. Tapper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 19 | |
| 2 | 2019 | 16 | |
| 3 | 2020 | 9 | |
| 4 | 2019 | 9 | |
| 5 | 2020 | 7 | |
| 6 | 2019 | 4 | |
| 7 | 2018 | 4 | |
| 8 | 2020 | 4 | |
| 9 | 2020 | 3 | |
| 10 | 2019 | 3 | |
| 11 | 2019 | 2 | |
| 12 | 2020 | 1 | |
| 13 | 2024 | 0 |
About Erin E. Tapper
Erin E. Tapper is a scholar working on Oncology, Molecular Biology, Immunology, Hematology and Genetics, having authored 13 papers that have together received 81 indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Multiple Myeloma Research and Treatments (2 papers), CRISPR and Genetic Engineering (2 papers), Virus-based gene therapy research (2 papers), Extracellular vesicles in disease (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Lanthanide and Transition Metal Complexes (1 paper) and Nanowire Synthesis and Applications (1 paper). The work is most often cited by research in Oncology (62 citations), Pathology and Forensic Medicine (12 citations), Genetics (6 citations), Immunology (11 citations) and Molecular Biology (35 citations). Erin E. Tapper has collaborated with scholars based in United States and Germany. Frequent co-authors include Mehrdad Hefazi, Michelle J. Cox, Michael W. Ruff, Saad S. Kenderian, Reona Sakemura, Claudia Manriquez Roman, Kendall J. Schick, Paulina Horvei, Robert B. Diasio and Neil E. Kay. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, JCO Precision Oncology, Cancer Research and Cytotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.